BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 32439830)

  • 1. GSG2 (Haspin) promotes development and progression of bladder cancer through targeting KIF15 (Kinase-12).
    Chen Y; Fu D; Zhao H; Cheng W; Xu F
    Aging (Albany NY); 2020 May; 12(10):8858-8879. PubMed ID: 32439830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Haspin knockdown can inhibit progression and development of pancreatic cancer in vitro and vivo.
    Han X; Kuang T; Ren Y; Lu Z; Liao Q; Chen W
    Exp Cell Res; 2019 Dec; 385(1):111605. PubMed ID: 31493385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Knockdown of GSG2 inhibits prostate cancer progression in vitro and in vivo.
    Yu F; Lin Y; Xu X; Liu W; Tang D; Zhou X; Wang G; Zheng Y; Xie A
    Int J Oncol; 2020 Jul; 57(1):139-150. PubMed ID: 32319597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GSG2 knockdown suppresses cholangiocarcinoma progression by regulating cell proliferation, apoptosis and migration.
    Zhou J; Nie W; Yuan J; Zhang Z; Mi L; Wang C; Huang R
    Oncol Rep; 2021 Jun; 45(6):. PubMed ID: 33846801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulator of cullins-1 expression knockdown suppresses the malignant progression of muscle-invasive transitional cell carcinoma by regulating mTOR/DEPTOR pathway.
    Wang W; Chen H; Liu Z; Qu P; Lan J; Chen H; Zou L; Qiu J
    Br J Cancer; 2016 Feb; 114(3):305-13. PubMed ID: 26742010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Germ cell-specific gene 2 accelerates cell cycle in epithelial ovarian cancer by inhibiting GSK3α-p27 cascade.
    Zhu K; Ma X; Guan X; Tong Y; Xie S; Wang Y; Zheng H; Guo L; Lu R
    J Mol Histol; 2024 Jun; 55(3):241-251. PubMed ID: 38613588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Down-regulation of CIT can inhibit the growth of human bladder cancer cells.
    Liu Z; Yan H; Yang Y; Wei L; Xia S; Xiu Y
    Biomed Pharmacother; 2020 Apr; 124():109830. PubMed ID: 31972359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Knockdown of
    Yu W; Liu W; Feng Y; Zhu C
    Genet Test Mol Biomarkers; 2022 Jan; 26(1):26-36. PubMed ID: 35089075
    [No Abstract]   [Full Text] [Related]  

  • 9. GSG2 Promotes Development and Predicts Poor Prognosis of Ovarian Cancer.
    Huang Y; Liu Y; Zhu K; Ma X; Lu R; Zhang M
    Cancer Manag Res; 2021; 13():499-508. PubMed ID: 33500663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Downregulation of integrin-linked kinase inhibits epithelial-to-mesenchymal transition and metastasis in bladder cancer cells.
    Zhu J; Pan X; Zhang Z; Gao J; Zhang L; Chen J
    Cell Signal; 2012 Jun; 24(6):1323-32. PubMed ID: 22570869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Small interfering RNA targeting integrin-linked kinase inhibited the growth and induced apoptosis in human bladder cancer cells.
    Gao J; Zhu J; Li HY; Pan XY; Jiang R; Chen JX
    Int J Biochem Cell Biol; 2011 Sep; 43(9):1294-304. PubMed ID: 21601006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. KIF15 promotes the evolution of gastric cancer cells through inhibition of reactive oxygen species-mediated apoptosis.
    Tao J; Sun G; Li Q; Zhi X; Li Z; He Z; Chen H; Zhou A; Ye J; Xu G; Guan W; Zhang W
    J Cell Physiol; 2020 Dec; 235(12):9388-9398. PubMed ID: 32342525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive analysis of differentially expressed genes associated with PLK1 in bladder cancer.
    Zhang Z; Zhang G; Gao Z; Li S; Li Z; Bi J; Liu X; Li Z; Kong C
    BMC Cancer; 2017 Dec; 17(1):861. PubMed ID: 29246203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Knockdown of GSG2 inhibits the development and progression of non-small cell lung cancer
    Zhang F; Qiu B; Ji Y; Zhang H; Song P; Sun N; Zhao L; Lv F; Yin L; Gao Y; Xue Q; Gao S; He J
    Cell Cycle; 2023 Jan; 22(2):153-164. PubMed ID: 35972887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Importin-11 overexpression promotes the migration, invasion, and progression of bladder cancer associated with the deregulation of CDKN1A and THBS1.
    Zhao J; Shi L; Zeng S; Ma C; Xu W; Zhang Z; Liu Q; Zhang P; Sun Y; Xu C
    Urol Oncol; 2018 Jun; 36(6):311.e1-311.e13. PubMed ID: 29602637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects and mechanisms of GSG2 in esophageal cancer progression.
    Geng C; Wang Q; Xing PF; Wang M; Tong SD; Zhou JY
    J Cancer Res Clin Oncol; 2023 Jul; 149(7):3409-3421. PubMed ID: 35939116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HASPIN is involved in the progression of gallbladder carcinoma.
    Zhu D; Gu X; Lin Z; Yu D; Wang J; Li L
    Exp Cell Res; 2020 May; 390(2):111863. PubMed ID: 31987787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LncRNA UCA1 Promotes Mitochondrial Function of Bladder Cancer via the MiR-195/ARL2 Signaling Pathway.
    Li HJ; Sun XM; Li ZK; Yin QW; Pang H; Pan JJ; Li X; Chen W
    Cell Physiol Biochem; 2017; 43(6):2548-2561. PubMed ID: 29130995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chondroitin polymerizing factor (CHPF) promotes development of malignant melanoma through regulation of CDK1.
    Sun W; Zhao F; Xu Y; Huang K; Guo X; Zheng B; Liu X; Luo Z; Kong Y; Xu M; Schadendorf D; Chen Y
    Cell Death Dis; 2020 Jul; 11(7):496. PubMed ID: 32612115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA methylation-dependent modulator of Gsg2/Haspin gene expression.
    Sato S; Maeda C; Hattori N; Yagi S; Tanaka S; Shiota K
    J Reprod Dev; 2011 Sep; 57(4):526-33. PubMed ID: 21606629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.